Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Study of Micafungin vs Amphotericin B Deoxycholate for Neonatal Candidiasis
2012-000780-24Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of micafungin in candidiasis and invasive candidiasis (2 arms), sponsored by Astellas Pharma. Primary endpoint: Fungal-free survival at one week after last dose. Started Jun 2012; status: completed.
02
Drugs
micafungin
03
Conditions
candidiasisinvasive candidiasis
Beyond the preview
Go deeper on 2012-000780-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000780-24.